AAAAAA
Results:
1-23
|
Results: 23
Authors:
SOLALCELIGNY P
LEPAGE E
BROUSSE N
TENDLER CL
BRICE P
HAIOUN C
GABARRE J
PIGNON B
TERTIAN G
BOUABDALLAH R
ROSSI JF
DOYEN C
COIFFIER B
Citation: P. Solalceligny et al., DOXORUBICIN-CONTAINING REGIMEN WITH OR WITHOUT INTERFERON-ALPHA-2B FOR ADVANCED FOLLICULAR LYMPHOMAS - FINAL ANALYSIS OF SURVIVAL AND TOXICITY IN THE GROUPE-DETUDE-DES-LYMPHOMES-FOLLICULAIRES-86 TRIAL, Journal of clinical oncology, 16(7), 1998, pp. 2332-2338
Authors:
COLE BF
SOLALCELIGNY P
GELBER RD
LEPAGE E
GISSELBRECHT C
REYES F
SEBBAN C
SUGANO D
TENDLER C
GOLDHIRSCH A
Citation: Bf. Cole et al., QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING, Journal of clinical oncology, 16(7), 1998, pp. 2339-2344
Authors:
SOLALCELIGNY P
COLOMBAT P
Citation: P. Solalceligny et P. Colombat, RELATIONSHIPS BETWEEN DOSE OR DOSE INTENS ITY AND EFFICACY OF CHEMOTHERAPY IN ADULT AGGRESSIVE NON-HODGKINS-LYMPHOMAS, Bulletin du cancer, 85(3), 1998, pp. 232-238
Authors:
DECAUDIN D
LEPAGE E
BROUSSE N
BRICE P
HAIOUN C
DOYEN C
TILLY H
COIFFER B
SOLALCELIGNY P
Citation: D. Decaudin et al., A PREDICTIVE MODEL FOR PROGNOSIS OF LOW-GRADE FOLLICULAR NON-HODGKINS-LYMPHOMAS - A PROPOSAL FROM THE GROUPE-DETUDE-DES-LYMPHOMES-FOLLICULAIRES (GELF), British Journal of Haematology, 102(1), 1998, pp. 144-144
Authors:
BRICE P
BASTION Y
LEPAGE E
BROUSSE N
HAIOUN C
MOREAU P
STRAETMANS N
TILLY H
TABAH I
SOLALCELIGNY P
Citation: P. Brice et al., COMPARISON IN LOW-TUMOR-BURDEN FOLLICULAR LYMPHOMAS BETWEEN AN INITIAL NO-TREATMENT POLICY, PREDNIMUSTINE, OR INTERFERON-ALFA - A RANDOMIZED STUDY FROM THE GROUPE-DETUDE-DES-LYMPHOMES-FOLLICULAIRES, Journal of clinical oncology, 15(3), 1997, pp. 1110-1117
Authors:
CANIONI D
LEPAGE E
SOLALCELIGNY P
PEUCHMAUR M
BROUSSE N
Citation: D. Canioni et al., HISTOLOGICAL PATTERN-ANALYSIS OF 406 BONE-MARROW BIOPSIES PREDICTS FOLLICULAR LYMPHOMA EVOLUTION, Blood, 90(10), 1997, pp. 3876-3876
Authors:
OZER H
SOLALCELIGNY P
TENDLER C
Citation: H. Ozer et al., INTEGRATED ANALYSIS OF THE SAFETY AND EFFICACY OF CONCURRENT THERAPY WITH RIFN-ALPHA AND CHEMOTHERAPY IN FOLLICULAR NHL, Blood, 90(10), 1997, pp. 3933-3933
Authors:
WIRT DP
GILES FJ
OKEN MM
SOLALCELIGNY P
BECK JR
Citation: Dp. Wirt et al., COST-EFFECTIVENESS OF INTERFERON-ALPHA ADDED TO CHEMOTHERAPY FOR HIGHTUMOR BURDEN FOLLICULAR NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 843-843
Authors:
WIERNIK P
OZER H
OKEN M
GILES F
SOLALCELIGNY P
COIFFIER B
Citation: P. Wiernik et al., PROGNOSTIC FACTORS IN PATIENT SELECTION FOR TREATMENT WITH INTERFERON-ALFA IN LOW-GRADE FOLLICULAR LYMPHOMA, Blood, 90(10), 1997, pp. 1503-1503
Authors:
REMAN O
BROUSSE N
SOLALCELIGNY P
MORELLO R
LEDERLIN P
CHRISTIAN D
MOREL P
BLANC M
PICO J
BOULAT O
CONROY T
GISSELBRECHT C
HAIOUN C
MARTIN D
TURLURE P
SIMON M
DABOUT D
LEPORRIER M
Citation: O. Reman et al., 2-CHLORODEOXYADENOSINE (2CDA) IN RELAPSING OR REFRACTORY FOLLICULAR LYMPHOMA, Blood, 90(10), 1997, pp. 1531-1531
Authors:
BELANGER C
SOLALCELIGNY P
NEIDHARDT EM
PRICE P
BROUSSE N
CASPARD H
HAIOUN C
BOSLY A
TILLY H
BORDESSOULE D
SEBBAN C
HARROUSSEAU JL
MOREL P
LEPORRIER M
Citation: C. Belanger et al., FLUDARABINE MONOPHOSPHATE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA - UPDATED ANALYSIS OF AND SALVAGE TREATMENT RESULTS FROM THE GROUPE-DETUDE-DES-LYMPHOMES-DE-DADULTE (GELA) TRIAL, Blood, 90(10), 1997, pp. 1534-1534
Authors:
DECAUDIN D
LEPAGE E
SOLALCELIGNY P
BROUSSE N
BRICE P
HAIOUN C
DOYEN C
TILLY H
COIFFIER B
Citation: D. Decaudin et al., LOW-GRADE FOLLICULAR LYMPHOMA - MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS IN 520 PATIENTS, Blood, 90(10), 1997, pp. 1742-1742
Authors:
SOLALCELIGNY P
Citation: P. Solalceligny, MANAGEMENT OF HISTOLOGICALLY INDOLENT NON-HODGKINS-LYMPHOMAS, Bailliere's clinical haematology, 9(4), 1996, pp. 669-687
Authors:
SOLALCELIGNY P
BRICE P
BROUSSE N
CASPARD H
BASTION Y
HAIOUN C
BOSLY A
TILLY H
BORDESSOULE D
SEBBAN C
HAROUSSEAU JL
MOREL P
DUPAS B
PLASSART F
VASILE N
FORT N
LEPORRIER M
Citation: P. Solalceligny et al., PHASE-II TRIAL OF FLUDARABINE MONOPHOSPHATE AS FIRST-LINE TREATMENT IN PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA - A MULTICENTER STUDY BY THE GROUPE DETUDE DES LYMPHOMES DE LADULTE, Journal of clinical oncology, 14(2), 1996, pp. 514-519
Authors:
SOLALCELIGNY P
LEPAGE E
BROUSSE N
TERTIAN G
THYSS A
REMAN O
SEBBAN C
PIGNON B
GISSELBRECHT C
COIFFIER B
COLE B
SUGANO D
TENDLER C
Citation: P. Solalceligny et al., A DOXORUBICIN CONTAINING REGIMEN WITH OR WITHOUT INTERFERON-ALPHA-2B (IFN-ALPHA 2B) IN ADVANCED FOLLICULAR LYMPHOMAS - FINAL ANALYSIS OF SURVIVAL, TOXICITY AND QUALITY-OF-LIFE OF THE GELF86 TRIAL, Blood, 88(10), 1996, pp. 1800-1800
Authors:
COLE BF
SOLALCELIGNY P
LEPAGE E
Citation: Bf. Cole et al., INTERFERON-ALPHA FOR THE TREATMENT OF ADVANCED FOLLICULAR LYMPHOMA - AN ANALYSIS OF QUALITY-OF-LIFE-ADJUSTED SURVIVAL, Blood, 86(10), 1995, pp. 1745-1745
Authors:
FENAUX P
MOREL P
BAUTERS F
PIGUET H
MONCONDUIT M
TILLY F
DESABLENS B
CLAISSE JF
ADJIZIAN JC
POTRON G
PIGNON B
LEPORRIER M
TROUSSARD X
REMAN O
BINET JL
DIGHIERO G
MALOUM K
MERLEBERAL H
RAPHAEL M
REISENLEITER M
LINASSIER C
LAMAGNERE JP
JAUBERT J
VASSELOM C
LEBLAY R
JACOMY D
GROSBOIS B
DREYFUS B
GUILHOT F
VAUGIER G
SOUTEYRAND P
LEPEU G
TOUCHAIS AM
BOUDJERRA N
BORDESSOULE M
SCHMIDT J
FACQUETDANIS J
SEBBAN C
ALLARD C
MURGUE B
SCHVED JF
ARNAUD A
CASSASSUS P
LEPRISE PY
DOR JF
TURPIN F
SOLALCELIGNY P
TERTIAN G
BERNARD JF
JAMES JM
REIGNER A
BLANC M
RAPP MJ
BOURGEOIS JP
LEJEUNE F
SALLES B
RENOUX M
GARIN B
CAMO J
TCHERNIA G
CECCALDI J
DEVIDAS A
LEMEVELLEPOURHIET A
BRIERE J
JANVIER M
NAJEAN Y
CHEVRET S
CHASTANG C
TRAVADE P
Citation: P. Fenaux et al., IS THE CHOP REGIMEN A GOOD TREATMENT FOR ADVANCED CLL - RESULTS FROM 2 RANDOMIZED CLINICAL-TRIALS, Leukemia & lymphoma, 13(5-6), 1994, pp. 449-456
Authors:
DEPIERRE A
CHASTANG C
QUOIX E
LEBEAU B
BLANCHON F
PAILLOT N
LEMARIE E
MILLERON B
MORO D
CLAVIER J
HERMAN D
TUCHAIS E
JACOULET P
BRECHOT JM
CORDIER JF
SOLALCELIGNY P
BADRI N
BESENVAL M
Citation: A. Depierre et al., VINORELBINE VERSUS VINORELBINE PLUS CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL, Annals of oncology, 5(1), 1994, pp. 37-42
Authors:
GANEM G
LAMBIN P
SOCIE G
GIRINSKY T
BOSQ J
PICO JL
SOLALCELIGNY P
COSSET JM
Citation: G. Ganem et al., POTENTIAL ROLE FOR LOW-DOSE LIMITED-FIELD RADIATION-THERAPY (2-X-2 GRAYS) IN ADVANCED LOW-GRADE NON-HODGKINS-LYMPHOMAS, Hematological oncology, 12(1), 1994, pp. 1-8
Authors:
SOLALCELIGNY P
BRICE P
BROUSSE N
BASTION Y
LEPORRIER M
HAIOUN C
BOSLY A
MOREL P
TILLY H
BORDESSOULE D
SEBBAN C
HAROUSSEAU JL
CASPARD H
DUPAS B
PLASSART F
VASILE N
FORT N
Citation: P. Solalceligny et al., PHASE-II TRIAL OF FLUDARABINE MONOPHOSPHATE (FAMP) AS 1ST LINE TREATMENT IN PATIENTS (PTS) WITH ADVANCED FOLLICULAR LYMPHOMA (FL) A MULTICENTER STUDY FROM THE GROUPE-DETUDE-DES-LYMPHOMES-DE-LADULTE (FRANCE AND) BELGIUM), Blood, 84(10), 1994, pp. 10000383-10000383
Authors:
LEGERRAVET MB
DEVERGNE O
PEUCHMAUR M
SOLALCELIGNY P
BROUSSE N
GAULARD P
GALANAUD P
EMILIE D
Citation: Mb. Legerravet et al., IN-SITU DETECTION OF ACTIVATED CYTOTOXIC-CELLS IN FOLLICULAR LYMPHOMAS, The American journal of pathology, 144(3), 1994, pp. 492-499
Authors:
BINET JL
FENAUX P
MOREL P
BAUTERS F
PIGUET H
MONCONDUIT M
TILLY F
DESABLENS B
CLAISSE JF
ADJIZIAN JC
POTRON G
PIGNON B
LEPORRIER M
TROUSSARD X
REMAN O
BINET JL
MALOUM K
MERLEBERAL H
RAPHAEL M
REISENLEITER M
LINASSIER C
LAMAGNERE JP
JAUBERT J
VASSELOM C
LEBLAY R
JACOMY D
GROSBOIS B
DREYFUS B
GUILHOT F
VAUGIER G
SOUTEYRAND P
LEPEU G
TOUCHIAS AM
BOUDJERRA N
BORDESSOULE M
TRAVADE P
SCHMIDT J
FACQUETDANIS J
SEBBAN C
ALLARD C
ROUSSET T
NAVARRO M
SCHVED JF
ARNAUD A
CASASSUS P
LEPRISE PY
DOR JF
TURPIN F
SOLALCELIGNY P
TERTIAN G
BERNARD JF
JAMES JM
REIGNER A
BLANC M
RAPP MJ
BOURGEOIS JP
LEJEUNE F
SALLES B
RENOUX M
GARIN B
CAMP J
TCHERNIA G
CECCALDI J
DEVIDAS A
LEMEVELLEPOURHIET A
BRIERE J
JANVIER M
NAJEAN Y
KERNEIS Y
COIFFIE B
DIGHIERO G
TEILLET F",GARNIER,DOIRON,STOPPA,ROGE,"MAIGRE M",MAISONNEUVE,"DIVINE M",CHERON,RODON,SIMON,THYSS,"BRION A",EGHBALI,CHRISTIAN,CARDE,AUTRAND,PAITEL,"SELIGMANN M",VIGNERON
Citation: Jl. Binet et al., TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA, Bailliere's clinical haematology, 6(4), 1993, pp. 867-878
Authors:
SOLALCELIGNY P
LEPAGE E
BROUSSE N
REYES F
HAIOUN C
LEPORRIER M
PEUCHMAUR M
BOSLY A
PARLIER Y
BRICE P
COIFFIER B
GISSELBRECHT C
Citation: P. Solalceligny et al., RECOMBINANT INTERFERON-ALFA-2B COMBINED WITH A REGIMEN CONTAINING DOXORUBICIN IN PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA, The New England journal of medicine, 329(22), 1993, pp. 1608-1614
Risultati:
1-23
|